Literature DB >> 14647293

Polycomb CBX7 has a unifying role in cellular lifespan.

Jesús Gil1, David Bernard, Dolores Martínez, David Beach.   

Abstract

In contrast to cancer cells and embryonic stem cells, the lifespan of primary human cells is finite. After a defined number of population doublings, cells enter in an irreversible growth-arrested state termed replicative senescence. Mutations of genes involved in immortalization can contribute to cancer. In a genetic screen for cDNAs bypassing replicative senescence of normal human prostate epithelial cells (HPrEC), we identified CBX7, a gene that encodes a Polycomb protein, as shown by sequence homology, its interaction with Ring1 and its localization to nuclear Polycomb bodies. CBX7 extends the lifespan of a wide range of normal human cells and immortalizes mouse fibroblasts by downregulating expression of the Ink4a/Arf locus. CBX7 does not inter-function or colocalize with Bmi1, and both can exert their actions independently of each other as shown by reverse genetics. CBX7 expression is downregulated during replicative senescence and its ablation by short-hairpin RNA (shRNA) treatment inhibited growth of normal cells though induction of the Ink4a/Arf locus. Taken together, these data show that CBX7 controls cellular lifespan through regulation of both the p16(Ink4a)/Rb and the Arf/p53 pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14647293     DOI: 10.1038/ncb1077

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.213


  131 in total

Review 1.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

Review 2.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

Review 3.  Assessing cell and organ senescence biomarkers.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

4.  Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing.

Authors:  Hong Lu; Julia Yue Cui; Sumedha Gunewardena; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Epigenetics       Date:  2012-07-09       Impact factor: 4.528

5.  Antiviral action of the tumor suppressor ARF.

Authors:  María A García; Manuel Collado; César Muñoz-Fontela; Ander Matheu; Laura Marcos-Villar; Javier Arroyo; Mariano Esteban; Manuel Serrano; Carmen Rivas
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

6.  Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain.

Authors:  Chunyan Ren; Keita Morohashi; Alexander N Plotnikov; Jean Jakoncic; Steven G Smith; Jiaojie Li; Lei Zeng; Yoel Rodriguez; Vivian Stojanoff; Martin Walsh; Ming-Ming Zhou
Journal:  Chem Biol       Date:  2015-02-05

7.  Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.

Authors:  Julien Vandamme; Pamela Völkel; Claire Rosnoblet; Perrine Le Faou; Pierre-Olivier Angrand
Journal:  Mol Cell Proteomics       Date:  2011-01-31       Impact factor: 5.911

8.  Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains.

Authors:  Jacob I Stuckey; Catherine Simpson; Jacqueline L Norris-Drouin; Stephanie H Cholensky; Junghyun Lee; Ryan Pasca; Nancy Cheng; Bradley M Dickson; Kenneth H Pearce; Stephen V Frye; Lindsey I James
Journal:  J Med Chem       Date:  2016-09-19       Impact factor: 7.446

9.  Polycomb Repressive Complex 2 and Trithorax modulate Drosophila longevity and stress resistance.

Authors:  Alex P Siebold; Rakhee Banerjee; Feng Tie; Daniel L Kiss; Jacob Moskowitz; Peter J Harte
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 10.  p53--a Jack of all trades but master of none.

Authors:  Melissa R Junttila; Gerard I Evan
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.